Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank92
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P92
Near historical high
vs 2Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025100.58%
2024-18.88%
202347.48%
2022-8191.77%
202196.94%
2020-21.52%
2019-19.65%
201819.21%
2017-457.57%
2016149.62%